Champions Oncology, Inc. (CSBR) stock
CSBRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 11, 2026Score 9/30246% above fair value
$4.71+0.05 (+1.18%)
Close on Nov 13, 2026Market cap $65.49MP/E –Yield –
Champions Oncology total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
No total debt figures for Champions Oncology
Champions Oncology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?